SunOpta Inc. (STKL) Trading Down 2.7%
Shares of SunOpta Inc. (NASDAQ:STKL) were down 2.7% during mid-day trading on Thursday . The stock traded as low as $5.05 and last traded at $5.06, with a volume of 128,673 shares changing hands. The stock had previously closed at $5.20.
Several analysts have issued reports on STKL shares. DA Davidson raised shares of SunOpta from a “neutral” rating to a “buy” rating and set a $6.00 target price on the stock in a research note on Wednesday, April 13th. Canaccord Genuity reaffirmed a “buy” rating and issued a $10.00 price target on shares of SunOpta in a research note on Wednesday, April 13th. Zacks Investment Research raised shares of SunOpta from a “sell” rating to a “hold” rating in a research note on Wednesday, May 4th. Finally, AltaCorp Capital reaffirmed an “outperform” rating on shares of SunOpta in a research note on Tuesday, June 21st. One analyst has rated the stock with a sell rating, three have issued a hold rating and five have given a buy rating to the company’s stock. SunOpta presently has a consensus rating of “Hold” and a consensus target price of $9.50.
The firm’s market capitalization is $435.24 million. The stock has a 50 day moving average price of $4.69 and a 200 day moving average price of $5.02.
SunOpta (NASDAQ:STKL) last announced its quarterly earnings data on Tuesday, May 10th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.04 by $0.01. The business had revenue of $352.30 million for the quarter, compared to analysts’ expectations of $351.60 million. During the same quarter in the previous year, the firm posted $0.08 earnings per share. The business’s revenue was up 16.1% on a year-over-year basis. On average, equities analysts anticipate that SunOpta Inc. will post $0.24 EPS for the current fiscal year.
In other SunOpta news, Director Douglas Greene acquired 50,000 shares of SunOpta stock in a transaction on Friday, May 20th. The shares were purchased at an average cost of $3.77 per share, with a total value of $188,500.00. Following the completion of the purchase, the director now owns 265,543 shares in the company, valued at $1,001,097.11. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Hendrik Jacobs acquired 7,000 shares of SunOpta stock in a transaction on Friday, May 20th. The stock was acquired at an average cost of $3.85 per share, for a total transaction of $26,950.00. Following the completion of the purchase, the chief executive officer now owns 41,638 shares of the company’s stock, valued at approximately $160,306.30. The disclosure for this purchase can be found here.
Several institutional investors have recently made changes to their positions in the company. Dimensional Fund Advisors LP boosted its position in shares of SunOpta by 56.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 151,928 shares of the company’s stock worth $1,039,000 after buying an additional 54,539 shares in the last quarter. Jennison Associates LLC boosted its position in shares of SunOpta by 6.8% in the fourth quarter. Jennison Associates LLC now owns 4,234,596 shares of the company’s stock worth $28,965,000 after buying an additional 270,963 shares in the last quarter. Baker Chad R purchased a new position in shares of SunOpta during the fourth quarter worth $2,977,000. Finally, Morgan Stanley boosted its position in shares of SunOpta by 123,646.6% in the fourth quarter. Morgan Stanley now owns 6,693,454 shares of the company’s stock worth $45,783,000 after buying an additional 6,688,045 shares in the last quarter.
SunOpta Inc operates businesses focused on a healthy products portfolio. The Company operates through two segments: Global Ingredients and Consumer Products. Its Global Ingredients segment aggregates its North American and international raw material sourcing and supply operating segments focused on the procurement, processing and sale of specialty and organic grains and seeds, fruits, grain- and cocoa-based ingredients, and other commodities.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.